News
Successful IGJ inspection completed
We are proud to share that last week BioConnection successfully completed a three-day inspection by the Healthcare and Youth Inspectorate (IGJ), conducted on behalf of the European Medicines Agency (EMA). This result confirms our commitment to quality and reliability...
Successful IGJ inspection completed
We are proud to share that last week BioConnection successfully completed a three-day inspection by the Healthcare and Youth Inspectorate (IGJ), conducted on behalf of the European Medicines Agency (EMA). This result confirms our commitment to quality and reliability...
BioConnection Receives European CMO of the Year Award 2024 in (Bio)pharmaceuticals
BioConnection is excited to share that we’ve been named the European Company of the Year in Biopharmaceutical Contract Manufacturing 2024 by Pharma...
Announcement: Richard Sewalt new Chief Commercial Officer (CCO) at BioConnection
Oss, NL September 2, 2024 We are excited to announce that Richard Sewalt has joined BioConnection as our new Chief Commercial Officer (CCO). With...
BioConnection appoints Dr. Gary M. Phillips as the new Chairman of the Supervisory Board
Oss, NL August 26, 2024 BioConnection is pleased to announce the appointment of Dr. Gary M. Phillips as the new Chairman of the Supervisory Board....
Strategic partnership AGC Biologics and BioConnection
AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), and BioConnection, a specialized...
BioConnection congratulates BioLineRx with their FDA approval of Aphexda
BioConnection congratulates BioLineRx with their FDA approval of Aphexda. We are proud that we have been able to support BioLineRx since the start...
Dutch CDMO BioConnection announces substantial investment by Gimv, supported by existing shareholders
New capital secures growth acceleration in services for small to medium sized biopharmaceutical companies and further enhancement of quality control...